Skip to main content

Table 3 Expression of target genes in patients with clear-cell renal-cell carcinoma characterized by high/low visceral adiposity

From: Association between visceral adiposity and DDX11 as a predictor of aggressiveness of small clear-cell renal-cell carcinoma: a prospective clinical trial

  Low visceral adiposity High visceral adiposity Pa Pb
mRNA expression (× 100) (N = 100) (N = 100)   
  Frozen tissue    
FOXC2 17.011 ± 33.556 7.896 ± 14.304 0.014 0.003
CLIP4 17.158 ± 32.455 9.365 ± 12.712 0.027 0.121
PBRM1 8.950 ± 11.257 7.032 ± 8.787 0.181 0.249
SETD2 1.476 ± 2.153 2.077 ± 2.316 0.059 0.759
BAP1 18.530 ± 59.910 1.649 ± 6.515 0.006 0.201
KDM5C 1.744 ± 2.704 1.954 ± 5.187 0.720 0.508
AQP1 1.283 ± 1.486 1.958 ± 0.981 < 0.001 0.008
DDX11 10.196 ± 10.477 1.890 ± 2.875 < 0.001 < 0.001
BAIAP2L1 3.007 ± 4.574 2.403 ± 3.139 0.277 0.051
TMEM38B 4.627 ± 7.711 7.055 ± 12.656 0.103 0.382
  Plasma    
FOXC2 16.708 ± 11.659 16.235 ± 8.215 0.740 0.705
CLIP4 16.848 ± 22.763 17.631 ± 22.080 0.805 0.895
PBRM1 2.452 ± 2.180 5.751 ± 41.896 0.417 0.099
SETD2 1.339 ± 1.690 2.346 ± 1.388 < 0.001 0.512
BAP1 98.325 ± 357.418 43.885 ± 244.658 0.210 0.633
KDM5C 13.468 ± 19.377 6.992 ± 9.286 0.003 0.776
AQP1 12.095 ± 19.380 8.017 ± 16.235 0.108 0.286
DDX11 5.484 ± 11.271 2.641 ± 2.657 0.016 0.081
BAIAP2L1 9.706 ± 15.835 4.965 ± 11.904 0.018 0.140
TMEM38B 17.087 ± 21.024 22.035 ± 33.570 0.213 0.523
  1. Data are shown as the means ± standard deviations
  2. aP values determined using Student’s t-test for univariate analysis
  3. bP values determined using logistic regression for multivariate analysis